FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Davis

Research Profile

Disorders

Activities & Behaviors

Schizophrenic Psychology

Concepts & Ideas

Anatomy

Brain

Chemicals & Drugs

Living Beings

Rats

Co-author Network

Publications

TOP 3
Panos Roussos; Larry J Siever; Todd Lencz; Anil K Malhotra; Panos Bitsios; Kenneth L Davis; Stella G Giakoumaki; Pavel Katsel; Vahram Haroutunian
Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.
Kenneth L Davis; Jaak Panksepp
The brain's emotional foundations of human personality and the Affective Neuroscience Personality Scales.
Cheuk Tang; Sylvan Wallenstein; Leonard White; Ying-Wei Wu; Stephanie Bowler; David M Carpenter; Emily Eaves; Lauren Flanagan; Joseph I Friedman; Stephanie Gottlieb; Thomas G McGinn; Erin Laverne Moshier; Johnny Ng; Vladan Novakovic; Michael Parrella; Kenneth L Davis
The effects of hypertension and body mass index on diffusion tensor imaging in schizophrenia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Panos Roussos; Larry J Siever; Todd Lencz; Anil K Malhotra; Panos Bitsios; Kenneth L Davis; Stella G Giakoumaki; Pavel Katsel; Vahram Haroutunian
Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(3):533-9.
2011: Kenneth L Davis; Jaak Panksepp
The brain's emotional foundations of human personality and the Affective Neuroscience Personality Scales.
Neuroscience and biobehavioral reviews 2011;35(9):1946-58.
2011: Cheuk Tang; Sylvan Wallenstein; Leonard White; Ying-Wei Wu; Stephanie Bowler; David M Carpenter; Emily Eaves; Lauren Flanagan; Joseph I Friedman; Stephanie Gottlieb; Thomas G McGinn; Erin Laverne Moshier; Johnny Ng; Vladan Novakovic; Michael Parrella; Kenneth L Davis
The effects of hypertension and body mass index on diffusion tensor imaging in schizophrenia.
Schizophrenia research 2011;130(1-3):94-100.
2011: Pavel Katsel; Mikhail V Pletnikov; Christopher A Ross; Weilun Tan; Bagrat Abazyan; Kenneth L Davis; Vahram Haroutunian
Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.
Schizophrenia research 2011;130(1-3):238-49.
2011: Joseph I Friedman; Jean-Pierre Lindenmayer; Frances Alcantara; Stephanie Bowler; Mohan Parak; Leonard White; Adel Iskander; Michael Parrella; David N Adler; Nicholas D Tsopelas; Wei-Yann Tsai; Vladan Novakovick; Philip D Harvey; Kenneth L Davis; Vladan Novakovic; Saurabh Kaushik
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(6):1289-95.
2011: N Takahashi; R H Walker; O Bozdagi-Gunal; Kenneth L Davis; N P Dorr; Gregory A Elder; Miguel A Gama Sosa; P R Hof; R J Koch; L Krug; J Moy; T Sakurai; Joseph Buxbaum
Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.
Translational psychiatry 2011;1():e8.
2011: Aurelian Radu; Gabriela Hristescu; Pavel Katsel; Vahram Haroutunian; Kenneth L Davis
Microarray database mining and cell differentiation defects in schizophrenia.
Advances in experimental medicine and biology 2011;696():67-74.
2011: Nagahide Takahashi; Takeshi Sakurai; Kenneth L Davis; Joseph Buxbaum
Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.
Progress in neurobiology 2011;93(1):13-24.
2010: Joseph I Friedman; Sylvan Wallenstein; Erin Moshier; Michael Parrella; Leonard White; Stephanie Bowler; Stephanie Gottlieb; Philip D Harvey; Thomas G McGinn; Lauren Flanagan; Kenneth L Davis
The effects of hypertension and body mass index on cognition in schizophrenia.
The American journal of psychiatry 2010;167(10):1232-9.
2010: Joseph T Glessner; Muredach P Reilly; Cecilia E Kim; Nagahide Takahashi; Anthony Albano; Cuiping Hou; Jonathan P Bradfield; Haitao Zhang; Patrick M A Sleiman; James H Flory; Marcin Imielinski; Edward C Frackelton; Rosetta M Chiavacci; Kelly A Thomas; Maria Garris; Frederick G Otieno; Michael Davidson; Mark Weiser; Abraham Reichenberg; Kenneth L Davis; Joseph I Friedman; Thomas P Cappola; Kenneth B Margulies; Daniel J Rader; Struan F A Grant; Joseph Buxbaum; Raquel E Gur; Hakon Hakonarson
Strong synaptic transmission impact by copy number variations in schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(23):10584-9.
2008: Pavel Katsel; Kenneth L Davis; Celeste Li; Weilun Tan; Elizabeth Greenstein; Lisa B Kleiner Hoffman; Vahram Haroutunian
Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2993-3009.
2008: David M Carpenter; Cheuk Tang; Joseph I Friedman; Patrick R Hof; Daniel G Stewart; Monte Buchsbaum; Philip D Harvey; Jack G Gorman; Kenneth L Davis
Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia.
Neuroreport 2008;19(14):1369-72.
2008: Joseph I Friedman; Cheuk Tang; David Carpenter; Monte Buchsbaum; James Schmeidler; Lauren Flanagan; Shana Golembo; Isabella Kanellopoulou; Johnny Ng; Patrick R Hof; Philip D Harvey; Nicholas D Tsopelas; Daniel Stewart; Kenneth L Davis
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.
The American journal of psychiatry 2008;165(8):1024-32.
2008: Daniel G Stewart; Kenneth L Davis
The lobotomist.
The American journal of psychiatry 2008;165(4):457-8.
2008: Joseph I Friedman; Kenneth L Davis; Linda Chang; Thomas Ernst; Nicholas D Tsopelas; Kai Zhong
Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjects.
Schizophrenia research 2008;100(1-3):356-8.
2008: Joseph I Friedman; T Vrijenhoek; S Markx; I M Janssen; Walter A Van Der Vliet; B H W Faas; N V Knoers; W Cahn; R S Kahn; Lisa Edelmann; Kenneth L Davis; Jeremy Silverman; Han G Brunner; Ad Geurts van Kessel; cisca wijmenga; R A Ophoff; Joris Veltman
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.
Molecular psychiatry 2008;13(3):261-6.
2008: Joseph Buxbaum; Lyudmila Georgieva; J J Young; C Plescia; Y Kajiwara; Y Jiang; Valentina Moskvina; Nadine Norton; Tim Peirce; Hywel Williams; Nick Craddock; L Carroll; Gabriel Corfas; Kenneth L Davis; Michael J Owen; Sheila Harroch; T Sakurai; Michael C O'Donovan
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.
Molecular psychiatry 2008;13(2):162-72.
2008: William Byne; Stella Dracheva; Benjamin Chin; James Schmeidler; Kenneth L Davis; Vahram Haroutunian
Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei.
Schizophrenia research 2008;98(1-3):118-28.
2007: Linda Chang; Joseph Friedman; Thomas Ernst; Kai Zhong; Nicholas D Tsopelas; Kenneth L Davis
Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.
Biological psychiatry 2007;62(12):1396-404.
2007: Vahram Haroutunian; Kenneth L Davis
Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(4):499-502.
2007: Vahram Haroutunian; Pavel Katsel; Stella Dracheva; Daniel G Stewart; Kenneth L Davis
Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(4):565-73.
2007: Sandeep K Gill; Margaret Ishak; Tomas Dobransky; Vahram Haroutunian; Kenneth L Davis; Rebecca Rylett
82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease.
Neurobiology of aging 2007;28(7):1028-40.
2007: Peter Szatmari; Andrew D Paterson; Lonnie Zwaigenbaum; Wendy Roberts; Jessica Brian; Xiao-Qing Liu; John B Vincent; Jennifer L Skaug; Ann P Thompson; Lili Senman; Lars Feuk; Cheng Qian; Susan E Bryson; Marshall B Jones; Christian R Marshall; Stephen W Scherer; Veronica J Vieland; Christopher Bartlett; La Vonne Mangin; Rhinda Goedken; Alberto Segre; Margaret Pericak-Vance; Michael Cuccaro; John Gilbert; Harry H Wright; Ruth K Abramson; Catalina Betancur; Thomas Bourgeron; Christopher Gillberg; Marion Leboyer; Joseph Buxbaum; Kenneth L Davis; Eric Hollander; Jeremy Silverman; Joachim Hallmayer; Linda Lotspeich; James S Sutcliffe; Jonathan L Haines; Susan E Folstein; Joseph Piven; Thomas H Wassink; Val Sheffield; Daniel Geschwind; Maja Bucan; W Ted Brown; Rita M Cantor; John N Constantino; T Conrad Gilliam; Martha Herbert; Clara Lajonchere; David Ledbetter; Christa Lese Martin; Janet Miller; Stan Nelson; Carol A Samango-Sprouse; Sarah J Spence; Sate Matthew; Rudolph E Tanzi; Hilary Coon; Geraldine Dawson; Bernie Devlin; Annette Estes; Pamela Flodman; Lambertus Klei; William M McMahon; Nancy J Minshew; Jeffrey Munson; Elena Korvatska; Patricia M Rodier; Gerard D Schellenberg; Moyra Smith; M Anne Spence; Chris Stodgell; Ping Guo Tepper; Ellen M Wijsman; Chang-En Yu; Bernadette Rogé; Carine Mantoulan; Kerstin Wittemeyer; Annemarie Poustka; Bärbel Felder; Sabine M Klauck; Claudia Schuster; Fritz Poustka; Sven Bölte; Sabine Feineis-Matthews; Evelyn Herbrecht; Gabi Schmötzer; John Tsiantis; Katerina Papanikolaou; Elena Maestrini; Elena Bacchelli; Francesca Blasi; Simona Carone; Claudio Toma; Herman Van Engeland; Maretha de Jonge; Chantal Kemner; Frederieke Koop; Frederike Koop; Marjolein Langemeijer; Marjolijn Langemeijer; Channa Hijmans; Channa Hijimans; Wouter G Staal; Gillian Baird; Patrick Bolton; Michael L Rutter; Emma Weisblatt; Jonathan Green; Catherine Aldred; Julie-Anne Wilkinson; Andrew Pickles; Ann Le Couteur; Tom Berney; Helen McConachie; Anthony J Bailey; Kostas Francis; Gemma Honeyman; Aislinn Hutchinson; Jeremy R Parr; Simon Wallace; Anthony P Monaco; Gabrielle Barnby; Kazuhiro Kobayashi; Janine A Lamb; Ines Sousa; Nuala Sykes; Edwin H Cook; Stephen J Guter; Bennett L Leventhal; Jeff Salt; Catherine Lord; Christina Corsello; Vanessa Hus; Daniel E Weeks; Fred Volkmar; Maïté Tauber; Eric Fombonne; Andy Shih; Kacie J Meyer
Mapping autism risk loci using genetic linkage and chromosomal rearrangements.
Nature genetics 2007;39(3):319-28.
2007: Robert E McCullumsmith; Daya Gupta; Monica Beneyto; Emily Kreger; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.
Schizophrenia research 2007;90(1-3):15-27.
2007: Cheuk Tang; Joseph Friedman; Dikoma Shungu; Linda Chang; Thomas Ernst; Daniel Stewart; Arash Hajianpour; David Carpenter; Johnny Ng; Xiangling Mao; Patrick R Hof; Monte Buchsbaum; Kenneth L Davis; Jack M Gorman
Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls.
BMC psychiatry 2007;7():25.
2006: Leonard White; Joseph I Friedman; Christopher R Bowie; Martin Evers; Philip D Harvey; Michael Parrella; Emilian Mihaila; Kenneth L Davis
Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics.
Schizophrenia research 2006;88(1-3):127-34.
2006: Monte Buchsbaum; Joseph Friedman; Bradley R Buchsbaum; King-Wai Chu; Erin A Hazlett; Randall E Newmark; Jason S Schneiderman; Yuliya Torosjan; Cheuk Tang; Patrick R Hof; Daniel Stewart; Kenneth L Davis; Jack Gorman
Diffusion tensor imaging in schizophrenia.
Biological psychiatry 2006;60(11):1181-7.
2006: Vahram Haroutunian; Pavel Katsel; Stella Dracheva; Kenneth L Davis
The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia.
The American journal of psychiatry 2006;163(10):1834-7.
2006: Joseph I Friedman; Kenneth L Davis
Special issue: Molecular mechanisms of schizophrenia.
Biological psychiatry 2006;60(6):527-9.
2006: Lyudmila Georgieva; Valentina Moskvina; Tim Peirce; Nadine Norton; Nicholas J Bray; Lesley Jones; Peter Holmans; Stuart Macgregor; Stanley Zammit; Jennifer Wilkinson; Hywel Williams; Ivan Nikolov; Nigel Williams; Dobril Ivanov; Kenneth L Davis; Vahram Haroutunian; Joseph Buxbaum; Nick Craddock; George Kirov; Michael J Owen; Michael C O'Donovan
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(33):12469-74.
2006: Jose R Carrión-Baralt; Christopher J Smith; Enrique Rossy-Fullana; Roberto Lewis-Fernández; Kenneth L Davis; Jeremy Silverman
Seasonality effects on schizophrenic births in multiplex families in a tropical island.
Psychiatry research 2006;142(1):93-7.
2006: Stella Dracheva; Kenneth L Davis; Benjamin Chin; Derek A Woo; James Schmeidler; Vahram Haroutunian
Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients.
Neurobiology of disease 2006;21(3):531-40.
2006: Philip D Harvey; Joseph I Friedman; Christopher R Bowie; Abraham Reichenberg; Susan R McGurk; Michael Parrella; Leonard White; Kenneth L Davis
Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia.
Journal of clinical and experimental neuropsychology 2006;28(2):178-92.
2006: Isak Prohovnik; Daniel P Perl; Kenneth L Davis; Leslie S Libow; G Lesser; Vahram Haroutunian
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
Neurology 2006;66(1):49-55.
2005: Pavel Katsel; Kenneth L Davis; Vahram Haroutunian
Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study.
Schizophrenia research 2005;79(2-3):157-73.
2005: Sarah M Clinton; Hisham M Ibrahim; Kirk A Frey; Kenneth L Davis; Vahram Haroutunian; James Meador-Woodruff
Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
The American journal of psychiatry 2005;162(10):1859-71.
2005: Pavel Katsel; Kenneth L Davis; Jack M Gorman; Vahram Haroutunian
Variations in differential gene expression patterns across multiple brain regions in schizophrenia.
Schizophrenia research 2005;77(2-3):241-52.
2005: Daya Shankar Gupta; Robert E McCullumsmith; Monica Beneyto; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
Synapse (New York, N.Y.) 2005;57(3):123-31.
2005: Joseph I Friedman; Ramoncito Ocampo; Zeinab Elbaz; Michael Parrella; Leonard White; Stephanie Bowler; Kenneth L Davis; Philip D Harvey
The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.
Journal of clinical psychopharmacology 2005;25(3):237-42.
2005: Emile G Bruneau; Robert E McCullumsmith; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia.
Schizophrenia research 2005;75(1):27-34.
2005: Michal Schnaider Beeri; Jeremy Silverman; Kenneth L Davis; Deborah B Marin; Hillel Z Grossman; James Schmeidler; Dushyant P Purohit; Daniel P Perl; Michael Davidson; Richard C Mohs; Vahram Haroutunian
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.
The journals of gerontology. Series A, Biological sciences and medical sciences 2005;60(4):471-5.
2005: Pavel Katsel; Kenneth L Davis; Vahram Haroutunian
Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.
International review of neurobiology 2005;63():41-82.
2004: Stella Dracheva; Sharif L Elhakem; Susan R McGurk; Kenneth L Davis; Vahram Haroutunian
GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia.
Journal of neuroscience research 2004;76(4):581-92.
2004: Susan R McGurk; Thomas Coleman; Philip D Harvey; Abraham Reichenberg; Leonard White; Joseph Friedman; Michael Parrella; Kenneth L Davis
Working memory performance in poor outcome schizophrenia: relationship to age and executive functioning.
Journal of clinical and experimental neuropsychology 2004;26(2):153-60.
2004: Nicolas Ramoz; Jennifer G Reichert; Christopher J Smith; Jeremy Silverman; Irina N Bespalova; Kenneth L Davis; Joseph Buxbaum
Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism.
The American journal of psychiatry 2004;161(4):662-9.
2004: Christopher R Bowie; Philip D Harvey; Patrick J Moriarty; Michael Parrella; Leonard White; Kenneth L Davis
A comprehensive analysis of verbal fluency deficit in geriatric schizophrenia.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2004;19(2):289-303.
2004: Larry J Siever; Kenneth L Davis
The pathophysiology of schizophrenia disorders: perspectives from the spectrum.
The American journal of psychiatry 2004;161(3):398-413.
2004: Helena T Mueller; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
Brain research. Molecular brain research 2004;121(1-2):60-9.
2004: Parvesh Bubber; Jicheng Tang; Vahram Haroutunian; Hui Xu; Kenneth L Davis; John P Blass; Gary Gibson
Mitochondrial enzymes in schizophrenia.
Journal of molecular neuroscience : MN 2004;24(2):315-21.
2004: Daniel G Stewart; Kenneth L Davis
Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.
International review of neurobiology 2004;59():381-424.
2003: Carmen Martin-Ruiz; Vahram H Haroutunian; Philip Long; Allan H Young; Kenneth L Davis; Elaine K Perry; Jennifer A Court
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.
Biological psychiatry 2003;54(11):1222-33.
2003: Philip D Harvey; Hillary Bertisch; Joseph I Friedman; Sue Marcus; Michael Parrella; Leonard White; Kenneth L Davis
The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of change.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2003;11(6):610-9.
2003: Monte Buchsbaum; Lina Shihabuddin; Adam Brickman; Ruben Miozzo; Radovan Prikryl; Robert Shaw; Kenneth L Davis
Caudate and putamen volumes in good and poor outcome patients with schizophrenia.
Schizophrenia research 2003;64(1):53-62.
2003: Mirsada Causevic; Nicolas Ramoz; Vahram Haroutunian; Kenneth L Davis; Joseph Buxbaum
Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype.
Journal of neuropathology and experimental neurology 2003;62(10):999-1005.
2003: Oksana Polesskaya; Vahram Haroutunian; Kenneth L Davis; Ivan Hernandez; Boris P Sokolov
Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia.
Journal of neuroscience research 2003;74(1):111-22.
2003: Kenneth L Davis; Vahram Haroutunian
Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Lancet 2003;362(9386):758.
2003: Daniel H Mathalon; Judy Rapoport; Kenneth L Davis; John H Krystal
Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry.
Archives of general psychiatry 2003;60(8):846-8; author reply 848-9.
2003: Patrick R Hof; Vahram Haroutunian; Victor L Friedrich; William Byne; Cristian Buitron; Daniel P Perl; Kenneth L Davis
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.
Biological psychiatry 2003;53(12):1075-85.
2003: Paul S Aisen; Kimberly Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald Thomas; Leon J Thal
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;289(21):2819-26.
2003: Sarah M Clinton; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia.
The American journal of psychiatry 2003;160(6):1100-9.
2003: Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
Archives of general psychiatry 2003;60(5):443-56.
2003: Michael Serby; Adam Brickman; Vahram Haroutunian; Dushyant P Purohit; Deborah B Marin; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2003;11(3):371-4.
2002: Judith Neugroschl; Kenneth L Davis
Biological markers in Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(6):660-77.
2002: Christopher R Bowie; Philip D Harvey; Patrick J Moriarty; Michael Parrella; Leonard White; Richard C Mohs; Kenneth L Davis
Cognitive assessment of geriatric schizophrenic patients with severe impairment.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2002;17(7):611-23.
2002: Patrick R Hof; Vahram Haroutunian; Christina Copland; Kenneth L Davis; Joseph Buxbaum
Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.
Neurochemical research 2002;27(10):1193-200.
2002: Carol A Tamminga; Charles Nemeroff; Randy D Blakely; Linda Brady; Cameron S Carter; Kenneth L Davis; ray dingledine; Jack M Gorman; Dimitri E Grigoriadis; David C Henderson; Robert B B Innis; John Killen; Thomas Laughren; William M McDonald; Greer M M Murphy; Steven M Paul; Matthew V Rudorfer; Edward A Sausville; Alan F Schatzberg; Edward M Scolnick; Trisha Suppes
Developing novel treatments for mood disorders: accelerating discovery.
Biological psychiatry 2002;52(6):589-609.
2002: Joseph I Friedman; Philip D Harvey; Susan R McGurk; Leonard White; Michael Parrella; Tenko Raykov; Thomas Coleman; David N Adler; Kenneth L Davis
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity.
The American journal of psychiatry 2002;159(8):1388-94.
2002: Vahram Haroutunian; Kenneth L Davis
Issues and perspectives on brain tissue banking.
Current psychiatry reports 2002;4(4):233-4.
2002: Martin R Gluck; Rohan G Thomas; Kenneth L Davis; Vahram Haroutunian
Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
The American journal of psychiatry 2002;159(7):1165-73.
2002: Monte Buchsbaum; Lina Shihabuddin; Erin A Hazlett; Johannes Schröder; M Mehmet Haznedar; Peter Powchik; Jacqueline Spiegel-Cohen; Tsechung Wei; Melissa B Singer; Kenneth L Davis
Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
Schizophrenia research 2002;55(1-2):25-40.
2002: Joseph I Friedman; David N Adler; Evelyn Howanitz; Philip D Harvey; Grant Brenner; Humberto Temporini; Leonard White; Michael Parrella; Kenneth L Davis
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
Biological psychiatry 2002;51(5):349-57.
2002: Philip D Harvey; Patrick J Moriarty; Christopher R Bowie; Joseph I Friedman; Michael Parrella; Leonard White; Kenneth L Davis
Cortical and subcortical cognitive deficits in schizophrenia: convergence of classifications based on language and memory skill areas.
Journal of clinical and experimental neuropsychology 2002;24(1):55-66.
2002: Kenneth L Davis
NSAID and Alzheimer's disease; possible answers and new questions.
Molecular psychiatry 2002;7(9):925-6.
2001: S Parvathy; Peter Davies; Vahram Haroutunian; Dushyant P Purohit; Kenneth L Davis; Richard C Mohs; H Park; Thomas M Moran; J Y Chan; Joseph Buxbaum
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
Archives of neurology 2001;58(12):2025-32.
2001: R E Smith; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.
Neuroreport 2001;12(13):2885-7.
2001: Joseph I Friedman; Philip D Harvey; Thomas Coleman; Patrick J Moriarty; Christopher R Bowie; Michael Parrella; Leonard White; D Adler; Kenneth L Davis
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
The American journal of psychiatry 2001;158(9):1441-8.
2001: Stella Dracheva; Salvatore A E Marras; Sharif L Elhakem; Fred Kramer; Kenneth L Davis; Vahram Haroutunian
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.
The American journal of psychiatry 2001;158(9):1400-10.
2001: R E Smith; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
The American journal of psychiatry 2001;158(9):1393-9.
2001: Joseph I Friedman; David N Adler; Humberto Temporini; Eileen M Kemether; Philip D Harvey; Leonard White; Michael Parrella; Kenneth L Davis
Guanfacine treatment of cognitive impairment in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(3):402-9.
2001: Philip D Harvey; Mark R Serper; Leonard White; Michael Parrella; Susan R McGurk; Patrick J Moriarty; Christopher R Bowie; Nehal P Vadhan; Joseph Friedman; Kenneth L Davis
The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
Comprehensive psychiatry 2001;42(4):306-13.
2001: Joseph Buxbaum; Jeremy Silverman; Christopher J Smith; M Kilifarski; Jennifer G Reichert; Eric Hollander; Brian A Lawlor; M Fitzgerald; David A Greenberg; Kenneth L Davis
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity.
American journal of human genetics 2001;68(6):1514-20.
2001: James Meador-Woodruff; Kenneth L Davis; Vahram Haroutunian
Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):545-52.
2001: Yaron Hakak; John R Walker; C Li; W H Wong; Kenneth L Davis; Joseph Buxbaum; Vahram Haroutunian; Allen Fienberg
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(8):4746-51.
2001: Johannes Schröder; Monte Buchsbaum; Lina Shihabuddin; Cheuk Tang; Tse-Chung Wei; Jacqueline Spiegel-Cohen; Erin A Hazlett; L Abel; C Luu-Hsia; T M Ciaravolo; D Marin; Kenneth L Davis
Patterns of cortical activity and memory performance in Alzheimer's disease.
Biological psychiatry 2001;49(5):426-36.
2001: Lon S Schneider; Pierre N. Tariot; Constantine G Lyketsos; Karen S Dagerman; Kenneth L Davis; Sonia M Davis; John K Hsiao; D V Jeste; Ira R Katz; Jason T Olin; B G Pollock; Peter V Rabins; Robert A Rosenheck; Gary W Small; Barry D Lebowitz; Jeffrey A Lieberman
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2001;9(4):346-60.
2001: Christopher R Bowie; Patrick J Moriarty; Philip D Harvey; Michael Parrella; Leonard White; Kenneth L Davis
Aggression in elderly schizophrenia patients: a comparison of nursing home and state hospital residents.
The Journal of neuropsychiatry and clinical neurosciences 2001;13(3):357-66.
2001: Patrick J Moriarty; D Lieber; A Bennett; Leonard White; Michael Parrella; Philip D Harvey; Kenneth L Davis
Gender differences in poor outcome patients with lifelong schizophrenia.
Schizophrenia bulletin 2001;27(1):103-13.
2000: Hisham M Ibrahim; AJ Hogg; Daniel J Healy; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.
The American journal of psychiatry 2000;157(11):1811-23.
2000: Deborah B Marin; M Dugue; J Schmeidler; J Santoro; Judith Neugroschl; GR Zaklad; Adam Brickman; E Schnur; J Hoblyn; Kenneth L Davis
The Caregiver Activity Survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's disease.
International journal of geriatric psychiatry 2000;15(8):680-6.
2000: Vahram Haroutunian; Michael Serby; Dushyant P Purohit; Daniel P Perl; Deborah B Marin; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.
Archives of neurology 2000;57(8):1145-50.
2000: Boris P Sokolov; A A Tcherepanov; Vahram Haroutunian; Kenneth L Davis
Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients.
Biological psychiatry 2000;48(3):184-96.
2000: Jeremy Silverman; C M Smith; Deborah B Marin; James Schmeidler; S Birstein; Melinda Lantz; Kenneth L Davis; Richard C Mohs
Has familial aggregation in Alzheimer's disease been overestimated?
International journal of geriatric psychiatry 2000;15(7):631-7.
2000: A S Schachter; Kenneth L Davis
Alzheimer's disease.
Dialogues in clinical neuroscience 2000;2(2):91-100.
2000: Philip D Harvey; Patrick J Moriarty; Joseph I Friedman; Leonard White; Michael Parrella; Richard C Mohs; Kenneth L Davis
Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas.
Biological psychiatry 2000;47(11):962-8.
2000: Philip D Harvey; H Jacobsen; D Mancini; Michael Parrella; Leonard White; Vahram Haroutunian; Kenneth L Davis
Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients.
Schizophrenia research 2000;43(1):3-9.
2000: Elaine K Perry; Carmen Martin-Ruiz; M Lee; M Griffiths; M Johnson; Margaret A Piggott; Vahram Haroutunian; Joseph Buxbaum; J Nãsland; Kenneth L Davis; Cecilia Gotti; Francesco Clementi; S Tzartos; O Cohen; H Soreq; Evelyn Jaros; Robert H Perry; Clive G Ballard; Ian G McKeith; Jennifer A Court
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
European journal of pharmacology 2000;393(1-3):215-22.
2000: J Näslund; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis; Peter Davies; Paul Greengard; Joseph Buxbaum
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
JAMA : the journal of the American Medical Association 2000;283(12):1571-7.
2000: Susan R McGurk; Patrick J Moriarty; Philip D Harvey; Michael Parrella; Leonard White; Kenneth L Davis
The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia.
Schizophrenia research 2000;42(1):47-55.
2000: Paul S Aisen; Kenneth L Davis; JD Berg; Kimberly Schafer; K Campbell; Ronald Thomas; Myron Weiner; Martin R Farlow; Mary Sano; Michael Grundman; Leon J Thal
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
Neurology 2000;54(3):588-93.
2000: Susan R McGurk; Patrick J Moriarty; Philip D Harvey; Michael Parrella; Leonard White; Joseph Friedman; Kenneth L Davis
Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients.
The Journal of neuropsychiatry and clinical neurosciences 2000;12(2):257-64.
2000: Sarah M Richardson-Burns; Vahram Haroutunian; Kenneth L Davis; Stanley J Watson Jr; James Meador-Woodruff
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus.
Biological psychiatry 2000;47(1):22-8.
2000: W Byne; C Stamu; Leonard White; Michael Parrella; Philip D Harvey; Kenneth L Davis
Prevalence and correlates of parkinsonism in an institutionalized population of geriatric patients with chronic schizophrenia.
International journal of geriatric psychiatry 2000;15(1):7-13.
1999: Kenneth L Davis; Richard C Mohs; Deborah B Marin; Dushyant P Purohit; Daniel P Perl; Melinda Lantz; G Austin; Vahram Haroutunian
Neuropeptide abnormalities in patients with early Alzheimer disease.
Archives of general psychiatry 1999;56(11):981-7.
1999: Joseph I Friedman; David N Adler; Kenneth L Davis
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease.
Biological psychiatry 1999;46(9):1243-52.
1999: Joseph I Friedman; Philip D Harvey; Eileen M Kemether; William Byne; Kenneth L Davis
Cognitive and functional changes with aging in schizophrenia.
Biological psychiatry 1999;46(7):921-8.
1999: Kenneth L Davis; D L Braff; Daniel R Weinberger
Protecting research subjects and psychiatric research: we can do both.
Biological psychiatry 1999;46(6):727-8.
1999: D Ehrenkrantz; Jeremy Silverman; C J Smith; S Birstein; Deborah B Marin; Richard C Mohs; Kenneth L Davis
Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease.
American journal of medical genetics 1999;88(4):378-82.
1999: D S Charney; Robert B Innis; Eric J Nestler; Kenneth L Davis; Charles Nemeroff; Daniel R Weinberger
Increasing public trust and confidence in psychiatric research.
Biological psychiatry 1999;46(1):1-2.
1999: Vahram Haroutunian; Dushyant P Purohit; Daniel P Perl; Deborah B Marin; K Khan; Melinda Lantz; Kenneth L Davis; Richard C Mohs
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.
Archives of neurology 1999;56(6):713-8.
1999: Farooq Amin; Jeremy Silverman; L J Siever; C J Smith; PJ Knott; Kenneth L Davis
Genetic antecedents of dopamine dysfunction in schizophrenia.
Biological psychiatry 1999;45(9):1143-50.
1999: Kenneth L Davis; Richard C Mohs; Deborah B Marin; Dushyant P Purohit; Daniel P Perl; Melinda Lantz; G Austin; Vahram Haroutunian
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
JAMA : the journal of the American Medical Association 1999;281(15):1401-6.
1999: C R Green; Deborah B Marin; Richard C Mohs; James Schmeidler; M Aryan; E Fine; Kenneth L Davis
The impact of behavioral impairment of functional ability in Alzheimer's disease.
International journal of geriatric psychiatry 1999;14(4):307-16.
1999: W Byne; Kenneth L Davis
The role of prefrontal cortex in the dopaminergic dysregulation of schizophrenia.
Biological psychiatry 1999;45(6):657-9.
1999: Jeremy Silverman; C J Smith; Deborah B Marin; S Birstein; M Mare; Richard C Mohs; Kenneth L Davis
Identifying families with likely genetic protective factors against Alzheimer disease.
American journal of human genetics 1999;64(3):832-8.
1999: Steven C Samuels; Jeremy Silverman; Deborah B Marin; Elaine Peskind; S G Younki; D A Greenberg; E Schnur; J Santoro; Kenneth L Davis
CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease.
Neurology 1999;52(3):547-51.
1999: Kenneth L Davis
Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
Geriatrics 1999;54(2):42-7; quiz 48.
1999: Philip D Harvey; Michael Parrella; Leonard White; Richard C Mohs; Michael Davidson; Kenneth L Davis
Convergence of cognitive and adaptive decline in late-life schizophrenia.
Schizophrenia research 1999;35(1):77-84.
1999: Philip D Harvey; Jeremy Silverman; Richard C Mohs; Michael Parrella; Leonard White; Peter Powchik; Michael Davidson; Kenneth L Davis
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients.
Biological psychiatry 1999;45(1):32-40.
1999: Joseph I Friedman; Humberto Temporini; Kenneth L Davis
Pharmacologic strategies for augmenting cognitive performance in schizophrenia.
Biological psychiatry 1999;45(1):1-16.
1998: Kenneth L Davis
"Ethical problems in psychiatric research".
The journal of behavioral health services & research 1998;25(4):467; author reply 468-9.
1998: Daniel J Healy; Vahram Haroutunian; P Powchik; M Davidson; Kenneth L Davis; Stanley J Watson Jr; James Meador-Woodruff
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(4):278-86.
1998: Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit; Deborah B Marin; K Khan; Melinda Lantz; Kenneth L Davis; Richard C Mohs
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
Archives of neurology 1998;55(9):1185-91.
1998: Deborah B Marin; Brenda Breuer; M L Marin; Jeremy Silverman; James Schmeidler; D Greenberg; S Flynn; M Mare; Melinda Lantz; Leslie S Libow; Richard R Neufeld; LD Altstiel; Kenneth L Davis; Richard C Mohs
The relationship between apolipoprotein E, dementia, and vascular illness.
Atherosclerosis 1998;140(1):173-80.
1998: Philip D Harvey; E Howanitz; Michael Parrella; Leonard White; Michael Davidson; Richard C Mohs; J Hoblyn; Kenneth L Davis
Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
The American journal of psychiatry 1998;155(8):1080-6.
1998: W Byne; L White; M Parella; R Adams; Philip D Harvey; Kenneth L Davis
Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment.
International journal of geriatric psychiatry 1998;13(7):473-9.
1998: Kenneth L Davis; Monte Buchsbaum; Lina Shihabuddin; Jacqueline Spiegel-Cohen; M Metzger; E Frecska; R S Keefe; Peter Powchik
Ventricular enlargement in poor-outcome schizophrenia.
Biological psychiatry 1998;43(11):783-93.
1998: SC Samuels; Kenneth L Davis
Experimental approaches to cognitive disturbance in Alzheimer's disease.
Harvard review of psychiatry 1998;6(1):11-22.
1998: SM Gabriel; Deborah B Marin; Paul S Aisen; Melinda Lantz; LD Altstiel; Kenneth L Davis; Richard C Mohs
Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old.
The American journal of psychiatry 1998;155(5):698-700.
1998: Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian; Peter Powchik; Michael Davidson; Kenneth L Davis
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
Archives of general psychiatry 1998;55(3):205-11.
1998: David S. Knopman; Lon S Schneider; Kenneth L Davis; S Gracon; F Smith
Long-term tacrine treatment effects.
Neurology 1998;50(2):567-8.
1998: Jeremy Silverman; C J Smith; S L Guo; Richard C Mohs; Larry J Siever; Kenneth L Davis
Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders.
Biological psychiatry 1998;43(2):97-106.
1998: Kenneth L Davis
Future therapeutic approaches to Alzheimer's disease.
The Journal of clinical psychiatry 1998;59 Suppl 11():14-6.
1998: Peter Powchik; Michael Davidson; Vahram Haroutunian; SM Gabriel; Dushyant P Purohit; Daniel P Perl; Philip D Harvey; Kenneth L Davis
Postmortem studies in schizophrenia.
Schizophrenia bulletin 1998;24(3):325-41.
1997: James Meador-Woodruff; Vahram Haroutunian; P Powchik; M Davidson; Kenneth L Davis; Stanley J Watson Jr
Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
Archives of general psychiatry 1997;54(12):1089-95.
1997: Deborah B Marin; C R Green; James Schmeidler; Philip D Harvey; Brian A Lawlor; T M Ryan; M Aryan; Kenneth L Davis; Richard C Mohs
Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.
Journal of the American Geriatrics Society 1997;45(11):1331-8.
1997: Kenneth L Davis; Deborah B Marin; R Kane; D Patrick; Elaine Peskind; Murray A Raskind; K L Puder
The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.
International journal of geriatric psychiatry 1997;12(10):978-88.
1997: SM Gabriel; Vahram Haroutunian; Peter Powchik; William Honer; Michael Davidson; Peter Davies; Kenneth L Davis
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Archives of general psychiatry 1997;54(6):559-66.
1997: Vahram Haroutunian; Nigel H Greig; X F Pei; Tada Utsuki; R Gluck; L D Acevedo; Kenneth L Davis; William C Wallace
Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions.
Brain research. Molecular brain research 1997;46(1-2):161-8.
1997: Paul S Aisen; Kenneth L Davis
The search for disease-modifying treatment for Alzheimer's disease.
Neurology 1997;48(5 Suppl 6):S35-41.
1997: G Li; M Aryan; Jeremy Silverman; Vahram Haroutunian; Daniel P Perl; S Birstein; Melinda Lantz; Deborah B Marin; Richard C Mohs; Kenneth L Davis
The validity of the family history method for identifying Alzheimer disease.
Archives of neurology 1997;54(5):634-40.
1997: G Li; Jeremy Silverman; C J Smith; M L Zaccario; C Wentzel-Bell; L J Siever; Richard C Mohs; Kenneth L Davis
Validity of the family history method for identifying schizophrenia-related disorders.
Psychiatry research 1997;70(1):39-48.
1997: RS Keefe; Jeremy Silverman; Richard C Mohs; Larry J Siever; Philip D Harvey; L Friedman; SE Roitman; R L DuPre; Christopher J Smith; James Schmeidler; Kenneth L Davis
Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia.
Archives of general psychiatry 1997;54(2):169-76.
1997: Philip D Harvey; J Lombardi; M Leibman; Michael Parrella; Leonard White; Peter Powchik; Richard C Mohs; Michael Davidson; Kenneth L Davis
Age-related differences in formal thought disorder in chronically hospitalized schizophrenic patients: a cross-sectional study across nine decades.
The American journal of psychiatry 1997;154(2):205-10.
1997: SC Samuels; Kenneth L Davis
A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.
Drug safety : an international journal of medical toxicology and drug experience 1997;16(1):66-77.
1996: Philip D Harvey; Michael Davidson; Leonard White; R S Keefe; J Hirschowitz; Richard C Mohs; Kenneth L Davis
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Biological psychiatry 1996;40(8):755-60.
1996: Lina Shihabuddin; Jeremy Silverman; Monte Buchsbaum; L J Seiver; C Luu; M K Germans; M Metzger; Richard C Mohs; C J Smith; Jacqueline Spiegel-Cohen; Kenneth L Davis
Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree.
Molecular psychiatry 1996;1(3):215-22.
1996: Paul S Aisen; Deborah B Marin; L Altstiel; C Goodwin; B Baruch; R Jacobson; T Ryan; Kenneth L Davis
A pilot study of prednisone in Alzheimer's disease.
Dementia (Basel, Switzerland) 1996;7(4):201-6.
1996: James Meador-Woodruff; S P Damask; J Wang; Vahram Haroutunian; Kenneth L Davis; Stanley J Watson Jr
Dopamine receptor mRNA expression in human striatum and neocortex.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(1):17-29.
1996: David S. Knopman; Lon S Schneider; Kenneth L Davis; S Talwalker; F Smith; T Hoover; S Gracon
Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group.
Neurology 1996;47(1):166-77.
1996: R S Keefe; E Frescka; S H Apter; Michael Davidson; J M Macaluso; J Hirschowitz; Kenneth L Davis
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
The American journal of psychiatry 1996;153(6):806-11.
1996: Jeremy Silverman; D A Greenberg; L D Altstiel; Larry J Siever; Richard C Mohs; C J Smith; G Zhou; T E Hollander; X P Yang; M Kedache; G Li; M L Zaccario; Kenneth L Davis
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree.
American journal of medical genetics 1996;67(2):162-71.
1996: Kenneth L Davis
Progress in understanding the pathogenesis of Alzheimer's disease.
Molecular psychiatry 1996;1(1):11-2.
1996: Michael Serby; C Mohan; M Aryan; L Williams; Richard C Mohs; Kenneth L Davis
Olfactory identification deficits in relatives of Alzheimer's disease patients.
Biological psychiatry 1996;39(5):375-7.
1996: S M Gabriel; Michael Davidson; Vahram Haroutunian; Peter Powchik; L M Bierer; Dushyant P Purohit; Daniel P Perl; Kenneth L Davis
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
Biological psychiatry 1996;39(2):82-91.
1996: Kenneth L Davis
Issues in accelerating the pace of development for neuroprotective agents.
Alzheimer disease and associated disorders 1996;10 Suppl 1():36-7.
1996: G Li; Jeremy Silverman; L D Altstiel; Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit; S Birstein; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Genetic epidemiology 1996;13(3):285-98.
1995: Deborah B Marin; L M Bierer; Brian A Lawlor; T M Ryan; R Jacobson; James Schmeidler; Richard C Mohs; Kenneth L Davis
L-deprenyl and physostigmine for the treatment of Alzheimer's disease.
Psychiatry research 1995;58(3):181-9.
1995: R S Keefe; SE Roitman; Philip D Harvey; C S Blum; R L DuPre; D M Prieto; M Davidson; Kenneth L Davis
A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia.
Schizophrenia research 1995;17(1):25-33.
1995: Brian A Lawlor; L M Bierer; T M Ryan; James Schmeidler; PJ Knott; L L Williams; Richard C Mohs; Kenneth L Davis
Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease.
Biological psychiatry 1995;38(3):185-8.
1995: W C Wallace; I Lieberburg; Dale Schenk; C Vigo-Pelfrey; Kenneth L Davis; Vahram Haroutunian
Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(7 Pt 1):4896-905.
1995: Brian A Lawlor; T M Ryan; L M Bierer; James Schmeidler; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis
Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease.
Biological psychiatry 1995;37(12):895-6.
1995: Kenneth L Davis; Peter Powchik
Tacrine.
Lancet 1995;345(8950):625-30.
1995: G Li; Jeremy Silverman; C J Smith; M L Zaccario; James Schmeidler; Richard C Mohs; Kenneth L Davis
Age at onset and familial risk in Alzheimer's disease.
The American journal of psychiatry 1995;152(3):424-30.
1995: L M Bierer; Vahram Haroutunian; S Gabriel; PJ Knott; L S Carlin; Dushyant P Purohit; Daniel P Perl; James Schmeidler; P Kanof; Kenneth L Davis
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.
Journal of neurochemistry 1995;64(2):749-60.
1995: L M Bierer; Patrick R Hof; Dushyant P Purohit; L Carlin; James Schmeidler; Kenneth L Davis; Daniel P Perl
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.
Archives of neurology 1995;52(1):81-8.
1995: L D Altstiel; Brian A Lawlor; Richard C Mohs; James Schmeidler; A Dalton; P Mehta; Kenneth L Davis
Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients.
Dementia (Basel, Switzerland) 1995;6(1):17-20.
1994: R G Stern; R S Kahn; M Davidson; R M Nora; Kenneth L Davis
Early response to clozapine in schizophrenia.
The American journal of psychiatry 1994;151(12):1817-8.
1994: Brian A Lawlor; T M Ryan; James Schmeidler; Richard C Mohs; Kenneth L Davis
Clinical symptoms associated with age at onset in Alzheimer's disease.
The American journal of psychiatry 1994;151(11):1646-9.
1994: L M Bierer; Paul S Aisen; Michael Davidson; T M Ryan; James Schmeidler; Kenneth L Davis
A pilot study of clonidine plus physostigmine in Alzheimer's disease.
Dementia (Basel, Switzerland) 1994;5(5):243-6.
1994: Paul S Aisen; Kenneth L Davis
Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
The American journal of psychiatry 1994;151(8):1105-13.
1994: Jeremy Silverman; G Li; M L Zaccario; C J Smith; James Schmeidler; Richard C Mohs; Kenneth L Davis
Patterns of risk in first-degree relatives of patients with Alzheimer's disease.
Archives of general psychiatry 1994;51(7):577-86.
1994: R S Keefe; Jeremy Silverman; SE Roitman; Philip D Harvey; M A Duncan; D Alroy; Larry J Siever; Kenneth L Davis; Richard C Mohs
Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests.
Psychiatry research 1994;53(1):1-12.
1994: R S Kahn; Michael Davidson; Larry J Siever; Serge Sevy; Kenneth L Davis
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine.
Biological psychiatry 1994;35(12):909-12.
1994: Vahram Haroutunian; Michael Davidson; P D Kanof; Daniel P Perl; Peter Powchik; M Losonczy; J McCrystal; Dushyant P Purohit; L M Bierer; Kenneth L Davis
Cortical cholinergic markers in schizophrenia.
Schizophrenia research 1994;12(2):137-44.
1994: Elaine K Perry; Vahram Haroutunian; Kenneth L Davis; R Levy; P Lantos; S Eagger; Mrinalini Honavar; A Dean; M Griffiths; Ian G McKeith
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
Neuroreport 1994;5(7):747-9.
1994: R G Stern; Richard C Mohs; Michael Davidson; James Schmeidler; Jeremy Silverman; Elisse Kramer; T Searcey; L Bierer; Kenneth L Davis
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
The American journal of psychiatry 1994;151(3):390-6.
1994: Andrew H Miller; G Sastry; A J Speranza; Brian A Lawlor; Richard C Mohs; T M Ryan; S M Gabriel; Michael Serby; James Schmeidler; Kenneth L Davis
Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease.
The American journal of psychiatry 1994;151(2):267-70.
1994: R S Kahn; Philip D Harvey; Michael Davidson; R S Keefe; S Apter; J M Neale; Richard C Mohs; Kenneth L Davis
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
Schizophrenia research 1994;11(3):217-24.
1994: Kenneth L Davis
Acceleration of the development of a treatment for Alzheimer's disease.
Neurobiology of aging 1994;15 Suppl 2():S55-6.
1993: L M Bierer; PJ Knott; James Schmeidler; Deborah B Marin; T M Ryan; Vahram Haroutunian; Dushyant P Purohit; Daniel P Perl; Richard C Mohs; Kenneth L Davis
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms.
Psychiatry research 1993;49(3):211-7.
1993: Claudia Schmauss; Vahram Haroutunian; Kenneth L Davis; Michael Davidson
Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):8942-6.
1993: W Wallace; S T Ahlers; J Gotlib; V Bragin; J Sugar; R Gluck; P A Shea; Kenneth L Davis; Vahram Haroutunian
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8712-6.
1993: R S Kahn; Michael Davidson; Larry J Siever; S Gabriel; S Apter; Kenneth L Davis
Serotonin function and treatment response to clozapine in schizophrenic patients.
The American journal of psychiatry 1993;150(9):1337-42.
1993: R S Kahn; Michael Davidson; PJ Knott; R G Stern; S Apter; Kenneth L Davis
Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Archives of general psychiatry 1993;50(8):599-605.
1993: C R Green; Richard C Mohs; James Schmeidler; M Aryan; Kenneth L Davis
Functional decline in Alzheimer's disease: a longitudinal study.
Journal of the American Geriatrics Society 1993;41(6):654-61.
1993: S M Gabriel; L M Bierer; V Harotunian; Dushyant P Purohit; Daniel P Perl; Kenneth L Davis
Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex.
Neuroscience letters 1993;155(1):116-20.
1993: Jeremy Silverman; Larry J Siever; T B Horvath; Emil F Coccaro; H Klar; Michael Davidson; L Pinkham; S H Apter; Richard C Mohs; Kenneth L Davis
Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders.
The American journal of psychiatry 1993;150(3):435-42.
1993: Dushyant P Purohit; Michael Davidson; Daniel P Perl; Peter Powchik; Vahram Haroutunian; L M Bierer; J McCrystal; M Losonczy; Kenneth L Davis
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.
Biological psychiatry 1993;33(4):255-60.
1993: Michael Davidson; R S Kahn; R G Stern; J Hirschowitz; S Apter; PJ Knott; Kenneth L Davis
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
Psychiatry research 1993;46(2):151-63.
1993: R Omar; Miguel Pappolla; I Argani; Kenneth L Davis
Acid phosphatase activity in senile plaques and cerebrospinal fluid of patients with Alzheimer's disease.
Archives of pathology & laboratory medicine 1993;117(2):166-9.
1993: L M Bierer; Paul S Aisen; Michael Davidson; T M Ryan; R G Stern; James Schmeidler; Kenneth L Davis
A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.
Alzheimer disease and associated disorders 1993;7(2):98-104.
1992: R S Keefe; Philip D Harvey; M F Lenzenweger; Michael Davidson; S H Apter; James Schmeidler; Richard C Mohs; Kenneth L Davis
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms.
Psychiatry research 1992;44(2):153-65.
1992: Kenneth L Davis; Leon J Thal; E R Gamzu; C S Davis; Robert F Woolson; S I Gracon; David Drachman; Lon S Schneider; Peter J Whitehouse; T M Hoover
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
The New England journal of medicine 1992;327(18):1253-9.
1992: G K Tsuboyama; S S Gabriel; B M Davis; M Davison; Brian A Lawlor; K Ware; Kenneth L Davis; Richard C Mohs
Neuroendocrine dysfunction in Alzheimer's disease: results following TRH stimulation.
Biological psychiatry 1992;32(2):195-8.
1992: R G Stern; Richard C Mohs; L M Bierer; Jeremy Silverman; James Schmeidler; Michael Davidson; Kenneth L Davis
Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes.
Psychiatry research 1992;42(2):101-10.
1992: Brian A Lawlor; G Tsuboyama; T Ryan; Richard C Mohs; B M Davis; Michael Davidson; S Gabriel; Kenneth L Davis
Agitation and postdexamethasone cortisol levels in Alzheimer's disease.
The American journal of psychiatry 1992;149(4):546-8.
1992: Brian A Lawlor; Kenneth L Davis
Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?
Biological psychiatry 1992;31(4):337-50.
1992: Kenneth L Davis
The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(2):312.
1992: R S Kahn; Michael Davidson; J Hirschowitz; R G Stern; B M Davis; S Gabriel; C Moore; Kenneth L Davis
Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects.
Psychiatry research 1992;41(2):155-61.
1992: Farooq Amin; Michael Davidson; Kenneth L Davis
Homovanillic acid measurement in clinical research: a review of methodology.
Schizophrenia bulletin 1992;18(1):123-48.
1992: Michael Davidson; R S Kahn; R G Stern; Philip D Harvey; R Keefe; PJ Knott; S Apter; L Webster; Kenneth L Davis
Measurements of plasma homovanillic acid in schizophrenic patients.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():521A-522A.
1991: L J Siever; Kenneth L Davis
A psychobiological perspective on the personality disorders.
The American journal of psychiatry 1991;148(12):1647-58.
1991: Kenneth L Davis; R S Kahn; G Ko; Michael Davidson
Dopamine in schizophrenia: a review and reconceptualization.
The American journal of psychiatry 1991;148(11):1474-86.
1991: Michael Davidson; R S Kahn; PJ Knott; R Kaminsky; M Cooper; K DuMont; S Apter; Kenneth L Davis
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
Archives of general psychiatry 1991;48(10):910-3.
1991: Philip D Harvey; Michael Davidson; Peter Powchik; J Schmeidler; R McQueeney; R Kaminsky; Kenneth L Davis
Time course and clinical predictors of treatment response in schizophrenia.
Schizophrenia research 1991;5(2):161-6.
1991: Larry J Siever; Farooq Amin; Emil F Coccaro; D Bernstein; RJ Kavoussi; O Kalus; T B Horvath; P Warne; Michael Davidson; Kenneth L Davis
Plasma homovanillic acid in schizotypal personality disorder.
The American journal of psychiatry 1991;148(9):1246-8.
1991: Philip D Harvey; K M Putnam; Michael Davidson; R S Kahn; Peter Powchik; R McQueeney; R S Keefe; Kenneth L Davis
Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.
Psychiatry research 1991;38(3):285-92.
1991: W C Wallace; V Bragin; Nikolaos K Robakis; Kumar Sambamurti; Dale VanderPutten; Carl R Merril; Kenneth L Davis; A C Santucci; Vahram Haroutunian
Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.
Brain research. Molecular brain research 1991;10(2):173-8.
1991: R S Keefe; D S Lobel; Richard C Mohs; Jeremy Silverman; Philip D Harvey; Michael Davidson; M F Losonczy; Kenneth L Davis
Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms.
Schizophrenia research 1991;4(2):71-9.
1991: R S Kahn; Michael Davidson; P Kanof; R T McQueeney; R R Singh; Kenneth L Davis
Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions.
Psychopharmacology 1991;103(1):95-8.
1991: P D Kanof; Richard C Mohs; J Gross; M Davidson; L M Bierer; Kenneth L Davis
Platelet phospholipid synthesis in Alzheimer's disease.
Neurobiology of aging 1991;12(1):65-9.
1991: A C Santucci; Vahram Haroutunian; Kenneth L Davis
Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats.
Clinical neuropharmacology 1991;14 Suppl 1():S1-8.
1991: Michael Davidson; R S Kahn; Peter Powchik; P Warne; M F Losonczy; R Kaminsky; S Apter; S Jaff; Kenneth L Davis
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Archives of general psychiatry 1991;48(1):73-6.
1990: Z Zemishlany; D Patterson; Kenneth L Davis; R G Hards
Glycinamide ribonucleotide synthetase activity in lymphocytes from patients with Alzheimer's disease and normal controls.
Biological psychiatry 1990;28(12):1058-60.
1990: Philip D Harvey; R S Keefe; J Moskowitz; K M Putnam; Richard C Mohs; Kenneth L Davis
Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals.
Psychiatry research 1990;33(2):179-88.
1990: Larry J Siever; Jeremy Silverman; T B Horvath; H Klar; Emil F Coccaro; R S Keefe; L Pinkham; P Rinaldi; Richard C Mohs; Kenneth L Davis
Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients.
Archives of general psychiatry 1990;47(7):634-40.
1990: Michael Davidson; Philip D Harvey; R L Bergman; Peter Powchik; R Kaminsky; M F Losonczy; Kenneth L Davis
Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients.
Archives of general psychiatry 1990;47(2):190-1.
1990: Vahram Haroutunian; P D Kanof; G Tsuboyama; Kenneth L Davis
Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.
Brain research 1990;507(2):261-6.
1990: L M Bierer; Daniel P Perl; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis
Neurofibrillary tangles, Alzheimer's disease and Lewy bodies.
Lancet 1990;335(8682):163.
1990: E R Gamzu; Leon J Thal; Kenneth L Davis
Therapeutic trials using tacrine and other cholinesterase inhibitors.
Advances in neurology 1990;51():241-5.
1990: Vahram Haroutunian; A C Santucci; Kenneth L Davis
Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.
Progress in brain research 1990;84():333-46.
1989: Blaine Greenwald; Elisse Kramer; Deborah B Marin; L B Laitman; C K Hermann; Richard C Mohs; Kenneth L Davis
Dementia with coexistent major depression.
The American journal of psychiatry 1989;146(11):1472-8.
1989: Vahram Haroutunian; P D Kanof; Kenneth L Davis
Interactions of forebrain cholinergic and somatostatinergic systems in the rat.
Brain research 1989;496(1-2):98-104.
1989: Kenneth L Davis
Toward a therapeutic strategy based on amyloid precursor protein: unanswered questions.
Neurobiology of aging 1989;10(5):475-6; discussion 477-8.
1989: G M Shutske; F A Pierrat; K J Kapples; M L Cornfeldt; M R Szewczak; F P Huger; G M Bores; Vahram Haroutunian; Kenneth L Davis
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
Journal of medicinal chemistry 1989;32(8):1805-13.
1989: Miguel Pappolla; R Omar; B Saran; A Andorn; M Suarez; C Pavia; A Weinstein; D Shank; Kenneth L Davis; W Burgdorfer
Concurrent neuroborreliosis and Alzheimer's disease: analysis of the evidence.
Human pathology 1989;20(8):753-7.
1989: Emil F Coccaro; Larry J Siever; H M Klar; G Maurer; K Cochrane; T B Cooper; Richard C Mohs; Kenneth L Davis
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior.
Archives of general psychiatry 1989;46(7):587-99.
1989: Vahram Haroutunian; P D Kanof; Kenneth L Davis
Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor.
Brain research 1989;487(1):200-3.
1989: P D Kanof; Emil F Coccaro; C A Johns; Michael Davidson; Larry J Siever; Kenneth L Davis
Cyclic-AMP production by polymorphonuclear leukocytes in psychiatric disorders.
Biological psychiatry 1989;25(4):413-20.
1989: R S Keefe; Richard C Mohs; M F Losonczy; Michael Davidson; Jeremy Silverman; T B Horvath; Kenneth L Davis
Premorbid sociosexual functioning and long-term outcome in schizophrenia.
The American journal of psychiatry 1989;146(2):206-11.
1989: Philip D Harvey; M Davidson; Kenneth L Davis; L Bastiaens
Change in subtype presentation in schizophrenics.
Comprehensive psychiatry 1989;30(1):114-6.
1989: R S Keefe; Larry J Siever; Richard C Mohs; A E Peterson; T R Mahon; R L Bergman; Kenneth L Davis
Eye tracking, schizophrenic symptoms, and schizotypal personality disorder.
European archives of psychiatry and neurological sciences 1989;239(1):39-42.
1989: A C Santucci; Vahram Haroutunian; G K Tsuboyama; P D Kanof; Kenneth L Davis
Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.
Progress in clinical and biological research 1989;317():1111-20.
1989: Michael Davidson; L M Bierer; R Kaminsky; T M Ryan; Kenneth L Davis
Combined administration of physostigmine and clonidine to patients with dementia of the Alzheimer type: a pilot safety study.
Alzheimer disease and associated disorders 1989;3(4):224-7.
1989: Jeremy Silverman; R S Keefe; Richard C Mohs; Kenneth L Davis
A study of the reliability of the family history method in genetic studies of Alzheimer disease.
Alzheimer disease and associated disorders 1989;3(4):218-23.
1989: R Halperin; J J Guerin; Kenneth L Davis
Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
Psychopharmacology 1989;98(3):386-91.
1989: K F Faull; P A Berger; J Kilkowski; P J Anderson; H Kraemer; Kenneth L Davis; J D Barchas
Corrections to a 1980 article on CSF monoamine metabolites.
The American journal of psychiatry 1989;146(1):118.
1988: Martin L Reite; Peter D Teale; J Zimmerman; Kenneth L Davis; J Whalen
Source location of a 50 msec latency auditory evoked field component.
Electroencephalography and clinical neurophysiology 1988;70(6):490-8.
1988: Kenneth L Davis; Michael Davidson; Ren-Kui Yang; B M Davis; Larry J Siever; Richard C Mohs; T Ryan; Emil F Coccaro; L Bierer; S D Targum
CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects.
Biological psychiatry 1988;24(6):710-2.
1988: John C S Breitner; EDMOND MURPHY; Jeremy Silverman; Richard C Mohs; Kenneth L Davis
Age-dependent expression of familial risk in Alzheimer's disease.
American journal of epidemiology 1988;128(3):536-48.
1988: Michael Davidson; B M Davis; L Bastiaens; J Macaluso; M Aryan; T Ryan; Kenneth L Davis
Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects.
The American journal of psychiatry 1988;145(8):1007-9.
1988: G M Shutske; F A Pierrat; M L Cornfeldt; M R Szewczak; F P Huger; G M Bores; Vahram Haroutunian; Kenneth L Davis
(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
Journal of medicinal chemistry 1988;31(7):1278-9.
1988: Michael Davidson; Kenneth L Davis
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
Archives of general psychiatry 1988;45(6):561-3.
1988: Emil F Coccaro; Larry J Siever; I A Kourides; Federico Adan; G Campbell; Kenneth L Davis
Central serotoninergic stimulation by fenfluramine challenge does not affect plasma thyrotropin-stimulating hormone levels in man.
Neuroendocrinology 1988;47(4):273-6.
1988: Michael Davidson; L Bastiaens; B M Davis; M B Shah; Kenneth L Davis
Endocrine changes in Alzheimer's disease.
Endocrinology and metabolism clinics of North America 1988;17(1):149-57.
1988: Michael Davidson; Z Zemishlany; Richard C Mohs; T B Horvath; P Powchik; John P Blass; Kenneth L Davis
4-Aminopyridine in the treatment of Alzheimer's disease.
Biological psychiatry 1988;23(5):485-90.
1988: P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; Barry D Greenberg; Kenneth L Davis; W Wallace; I Lieberburg; F Fuller
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.
Nature 1988;331(6156):525-7.
1988: John C S Breitner; Jeremy Silverman; Richard C Mohs; Kenneth L Davis
Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations.
Neurology 1988;38(2):207-12.
1988: Michael Davidson; L Bastiaens; B M Davis; M B Shah; Kenneth L Davis
Endocrine changes in Alzheimer's disease.
Neurologic clinics 1988;6(1):149-57.
1988: M Davidson; P Powchik; Kenneth L Davis
Pisa syndrome in Alzheimer's disease.
Biological psychiatry 1988;23(2):213.
1988: J E Sorokin; Bruno Giordani; Richard C Mohs; M F Losonczy; M Davidson; Larry J Siever; T A Ryan; Kenneth L Davis
Memory impairment in schizophrenic patients with tardive dyskinesia.
Biological psychiatry 1988;23(2):129-35.
1988: Elisse Kramer; Richard C Mohs; M Aryan; D Lobel; Jeremy Silverman; Michael Davidson; Kenneth L Davis
Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report.
Psychopharmacology bulletin 1988;24(3):458-62.
1988: Vahram Haroutunian; P Knott; Kenneth L Davis
Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic function.
Psychopharmacology bulletin 1988;24(3):341-4.
1988: A J Friedhoff; DAVID PICKAR; Julius Axelrod; I Creese; Kenneth L Davis; D W Gallagher; Paul Greengard; D Housman; J W Maas; E Richelson
Neurochemistry and neuropharmacology.
Schizophrenia bulletin 1988;14(3):399-412.
1988: R S Keefe; Richard C Mohs; M Davidson; M F Losonczy; Jeremy Silverman; J C Lesser; T B Horvath; Kenneth L Davis
Kraepelinian schizophrenia: a subgroup of schizophrenia?
Psychopharmacology bulletin 1988;24(1):56-61.
1988: P D Kanof; C A Johns; Michael Davidson; Larry J Siever; Emil F Coccaro; Kenneth L Davis
Platelet alpha 2-adrenergic receptor function in psychiatric disorders.
Psychiatry research 1988;23(1):11-22.
1987: Z Zemishlany; M Davidson; Kenneth L Davis
[Cholinergic agents in the treatment of Alzheimer's disease].
Harefuah 1987;113(12):401-4.
1987: M Davidson; M F Losonczy; Richard C Mohs; J C Lesser; Peter Powchik; L B Freed; B M Davis; V V Mykytyn; Kenneth L Davis
Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1987;1(1):17-23.
1987: P D Kanof; Michael Davidson; C A Johns; Richard C Mohs; Kenneth L Davis
Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.
The American journal of psychiatry 1987;144(12):1556-60.
1987: Emil F Coccaro; Larry J Siever; H Klar; K Rubenstein; E Benjamin; Kenneth L Davis
Diminished prolactin responses to repeated fenfluramine challenge in man.
Psychiatry research 1987;22(3):257-9.
1987: Jeremy Silverman; Richard C Mohs; Michael Davidson; M F Losonczy; R S Keefe; John C S Breitner; J E Sorokin; Kenneth L Davis
Familial schizophrenia and treatment response.
The American journal of psychiatry 1987;144(10):1271-6.
1987: Eric Hollander; Michael Davidson; Richard C Mohs; T B Horvath; B M Davis; Z Zemishlany; Kenneth L Davis
RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.
Biological psychiatry 1987;22(9):1067-78.
1987: R S Keefe; Richard C Mohs; M F Losonczy; M Davidson; Jeremy Silverman; K S Kendler; T B Horvath; R Nora; Kenneth L Davis
Characteristics of very poor outcome schizophrenia.
The American journal of psychiatry 1987;144(7):889-95.
1987: M Davidson; R S Keefe; Richard C Mohs; Larry J Siever; M F Losonczy; T B Horvath; Kenneth L Davis
L-dopa challenge and relapse in schizophrenia.
The American journal of psychiatry 1987;144(7):934-8.
1987: Richard C Mohs; John C S Breitner; Jeremy Silverman; Kenneth L Davis
Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age.
Archives of general psychiatry 1987;44(5):405-8.
1987: Myron Weiner; B M Davis; Richard C Mohs; Kenneth L Davis
Influence of age and relative weight on cortisol suppression in normal subjects.
The American journal of psychiatry 1987;144(5):646-9.
1987: M Davidson; A B Giordani; Richard C Mohs; V V Mykytyn; S Platt; Z S Aryan; Kenneth L Davis
Control of exogenous factors affecting plasma homovanillic acid concentration.
Psychiatry research 1987;20(4):307-12.
1987: Kenneth L Davis; Eric Hollander; M Davidson; B M Davis; Richard C Mohs; T B Horvath
Induction of depression with oxotremorine in patients with Alzheimer's disease.
The American journal of psychiatry 1987;144(4):468-71.
1987: P D Kanof; Emil F Coccaro; C A Johns; Larry J Siever; Kenneth L Davis
Platelet [3H]imipramine binding in psychiatric disorders.
Biological psychiatry 1987;22(3):278-86.
1987: Vahram Haroutunian; R Mantin; G A Campbell; G K Tsuboyama; Kenneth L Davis
Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry.
Brain research 1987;403(2):234-42.
1987: Michael Davidson; A B Giordani; Richard C Mohs; T B Horvath; B M Davis; P Powchik; Kenneth L Davis
Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration.
Archives of general psychiatry 1987;44(2):189-90.
1987: Michael Davidson; Richard C Mohs; Eric Hollander; Z Zemishlany; P Powchik; T Ryan; Kenneth L Davis
Lecithin and piracetam in Alzheimer's disease.
Biological psychiatry 1987;22(1):112-4.
1987: Michael Davidson; M F Losonczy; Richard C Mohs; P Powchick; L B Freed; R Kaminsky; Kenneth L Davis
Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.
Psychopharmacology bulletin 1987;23(3):407-10.
1987: Larry J Siever; Emil F Coccaro; Z Zemishlany; Jeremy Silverman; H Klar; M F Losonczy; Michael Davidson; R Friedman; Richard C Mohs; Kenneth L Davis
Psychobiology of personality disorders: pharmacologic implications.
Psychopharmacology bulletin 1987;23(3):333-6.
1986: Kenneth L Davis; Richard C Mohs
Cholinergic drugs in Alzheimer's disease.
The New England journal of medicine 1986;315(20):1286-7.
1986: Vahram Haroutunian; P D Kanof; G K Tsuboyama; G A Campbell; Kenneth L Davis
Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):385-93.
1986: Vahram Haroutunian; P D Kanof; Kenneth L Davis
Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor.
Brain research 1986;386(1-2):397-9.
1986: Jeremy Silverman; John C S Breitner; Richard C Mohs; Kenneth L Davis
Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias.
The American journal of psychiatry 1986;143(10):1279-82.
1986: P D Kanof; C Johns; M Davidson; L J Siever; E F Coccaro; Kenneth L Davis
Prostaglandin receptor sensitivity in psychiatric disorders.
Archives of general psychiatry 1986;43(10):987-93.
1986: Eric Hollander; Richard C Mohs; Kenneth L Davis
Antemortem markers of Alzheimer's disease.
Neurobiology of aging 1986;7(5):367-407.
1986: M F Losonczy; I S Song; Richard C Mohs; A A Mathé; M Davidson; B M Davis; Kenneth L Davis
Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
The American journal of psychiatry 1986;143(9):1113-8.
1986: M F Losonczy; I S Song; Richard C Mohs; N A Small; M Davidson; C A Johns; Kenneth L Davis
Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures.
The American journal of psychiatry 1986;143(8):976-81.
1986: Blaine Greenwald; A A Mathé; Richard C Mohs; M I Levy; C A Johns; Kenneth L Davis
Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
The American journal of psychiatry 1986;143(4):442-6.
1986: Kenneth L Davis; B M Davis; Blaine Greenwald; Richard C Mohs; A A Mathé; C A Johns; T B Horvath
Cortisol and Alzheimer's disease, I: Basal studies.
The American journal of psychiatry 1986;143(3):300-5.
1986: M Davidson; K S Kendler; Richard C Mohs; Eric Hollander; T Ryan; Kenneth L Davis
Effect of apomorphine infusion on plasma homovanillic acid in normal subjects.
Journal of psychiatric research 1986;20(2):131-5.
1986: M Davidson; Richard C Mohs; Eric Hollander; B M Davis; T Ryan; T B Horvath; Kenneth L Davis
Physostigmine in patients with Alzheimer's disease.
Psychopharmacology bulletin 1986;22(1):101-5.
1986: Eric Hollander; Richard C Mohs; Kenneth L Davis
Cholinergic approaches to the treatment of Alzheimer's disease.
British medical bulletin 1986;42(1):97-100.
1985: K S Kendler; C C Masterson; Kenneth L Davis
Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness.
The British journal of psychiatry : the journal of mental science 1985;147():524-31.
1985: Richard C Mohs; B M Davis; Blaine Greenwald; A A Mathé; C A Johns; T B Horvath; Kenneth L Davis
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.
Journal of the American Geriatrics Society 1985;33(11):749-57.
1985: B M Davis; Richard C Mohs; Blaine Greenwald; A A Mathé; C A Johns; T B Horvath; Kenneth L Davis
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.
Journal of the American Geriatrics Society 1985;33(11):741-8.
1985: M Davidson; K S Kendler; B M Davis; T B Horvath; Richard C Mohs; Kenneth L Davis
Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
Psychiatry research 1985;16(2):95-9.
1985: Vahram Haroutunian; P Kanof; Kenneth L Davis
Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.
Life sciences 1985;37(10):945-52.
1985: L J Siever; Kenneth L Davis
Overview: toward a dysregulation hypothesis of depression.
The American journal of psychiatry 1985;142(9):1017-31.
1985: Richard C Mohs; Kenneth L Davis
Interaction of choline and scopolamine in human memory.
Life sciences 1985;37(2):193-7.
1985: P D Kanof; Blaine Greenwald; Richard C Mohs; Kenneth L Davis
Red blood cell choline. II: Kinetics in Alzheimer's disease.
Biological psychiatry 1985;20(4):375-83.
1985: Blaine Greenwald; J Edasery; Richard C Mohs; N Shah; G G Trigos; Kenneth L Davis
Red blood cell choline. I: Choline in Alzheimer's disease.
Biological psychiatry 1985;20(4):367-74.
1985: Stephen Irwin Deutsch; R Halperin; M Stanley; Kenneth L Davis
Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat.
Neurochemical research 1985;10(4):491-8.
1985: Kenneth L Davis; M Davidson; Richard C Mohs; K S Kendler; B M Davis; C A Johns; Y DeNigris; T B Horvath
Plasma homovanillic acid concentration and the severity of schizophrenic illness.
Science (New York, N.Y.) 1985;227(4694):1601-2.
1985: B M Davis; Kenneth L Davis; Richard C Mohs; A A Mathé; A B Rothpearl; C A Johns; M I Levy; T B Horvath
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
Archives of general psychiatry 1985;42(3):259-64.
1985: R P Roos; Kenneth L Davis; Herbert Y Meltzer
Immunoglobulin studies in patients with psychiatric diseases.
Archives of general psychiatry 1985;42(2):124-8.
1985: Steven J Schleifer; Steven E Keller; Samuel Siris; Kenneth L Davis; M Stein
Depression and immunity. Lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniorrhaphy.
Archives of general psychiatry 1985;42(2):129-33.
1985: Richard C Mohs; B M Davis; C A Johns; A A Mathé; Blaine Greenwald; T B Horvath; Kenneth L Davis
Oral physostigmine treatment of patients with Alzheimer's disease.
The American journal of psychiatry 1985;142(1):28-33.
1985: Vahram Haroutunian; E Barnes; Kenneth L Davis
Cholinergic modulation of memory in rats.
Psychopharmacology 1985;87(3):266-71.
1984: W G Rosen; Richard C Mohs; C A Johns; N S Small; K S Kendler; T B Horvath; Kenneth L Davis
Positive and negative symptoms in schizophrenia.
Psychiatry research 1984;13(4):277-84.
1984: W G Rosen; Richard C Mohs; Kenneth L Davis
A new rating scale for Alzheimer's disease.
The American journal of psychiatry 1984;141(11):1356-64.
1984: K S Kendler; Kenneth L Davis
Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
Psychiatry research 1984;13(1):51-8.
1984: Kenneth L Davis; B M Davis; A A Mathé; Richard C Mohs; A B Rothpearl; M I Levy; L K Gorman; P Berger
Age and the dexamethasone suppression test in depression.
The American journal of psychiatry 1984;141(7):872-4.
1984: Stephen Irwin Deutsch; W H Oldendorf; Kenneth L Davis
Brain uptake indices of guanidine and 4-aminopyridine.
Life sciences 1984;34(23):2279-80.
1984: Steven J Schleifer; Steven E Keller; A T Meyerson; M J Raskin; Kenneth L Davis; M Stein
Lymphocyte function in major depressive disorder.
Archives of general psychiatry 1984;41(5):484-6.
1984: M I Levy; B M Davis; Richard C Mohs; K S Kendler; A A Mathé; G Trigos; T B Horvath; Kenneth L Davis
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
Archives of general psychiatry 1984;41(5):520-4.
1984: M F Losonczy; Richard C Mohs; Kenneth L Davis
Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
Psychiatry research 1984;12(1):79-87.
1984: M Fiori; Kenneth L Davis
Possible clinical applications of laboratory tests in depression.
The Journal of clinical psychiatry 1984;45(4 Pt 2):6-11.
1984: K S Kendler; C C Masterson; R Ungaro; Kenneth L Davis
A family history study of schizophrenia-related personality disorders.
The American journal of psychiatry 1984;141(3):424-7.
1984: K S Kendler; Kenneth L Davis
Genetic control of apomorphine-induced climbing behavior in two inbred mouse strains.
Brain research 1984;293(2):343-51.
1984: N E Small; Richard C Mohs; R Halperin; W G Rosen; C Masterson; K S Kendler; T B Horvath; Kenneth L Davis
A study of the reliability of reported premorbid adjustment in schizophrenic patients.
Biological psychiatry 1984;19(2):203-11.
1984: C A Johns; M I Levy; B M Davis; Richard C Mohs; K S Kendler; A A Mathe; G Trigos; T B Horvath; Kenneth L Davis
Apomorphine and schizophrenia.
Psychopharmacology bulletin 1984;20(1):103-7.
1984: L J Siever; Kenneth L Davis
Dysregulation of the noradrenergic system in depression.
Psychopharmacology bulletin 1984;20(3):500-4.
1983: Stephen Irwin Deutsch; Richard C Mohs; M I Levy; A B Rothpearl; D Stockton; T Horvath; A Coco; Kenneth L Davis
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Biological psychiatry 1983;18(12):1363-73.
1983: R Halperin; J J Guerin; Kenneth L Davis
Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.
Life sciences 1983;33(6):585-92.
1983: M I Levy; K S Kendler; A A Mathé; Richard C Mohs; Y Denigris; G G Trigos; A Axiotis; A Rothpearl; Kenneth L Davis
Antipsychotic efficacy of fluotracen: a clinical trial.
Journal of clinical psychopharmacology 1983;3(3):189-92.
1983: M I Levy; B M Davis; Richard C Mohs; G C Trigos; A A Mathé; Kenneth L Davis
Gamma-hydroxybutyrate in the treatment of schizophrenia.
Psychiatry research 1983;9(1):1-8.
1983: Stephen Irwin Deutsch; Kenneth L Davis
Schizophrenia: a review of diagnostic and biological issues. II. Biological issues.
Hospital & community psychiatry 1983;34(5):423-37.
1983: Blaine Greenwald; Richard C Mohs; Kenneth L Davis
Neurotransmitter deficits in Alzheimer's disease: criteria for significance.
Journal of the American Geriatrics Society 1983;31(5):310-6.
1983: Stephen Irwin Deutsch; Kenneth L Davis
Schizophrenia: a review of diagnostic and biological issues. I. Diagnosis and prognosis.
Hospital & community psychiatry 1983;34(4):313-22.
1983: K S Kendler; Richard C Mohs; Kenneth L Davis
The effects of diet and physical activity on plasma homovanillic acid in normal human subjects.
Psychiatry research 1983;8(3):215-23.
1983: G M Pepper; Kenneth L Davis; B M Davis; D T Krieger
DST in depression is unaffected by altering the clock time of its administration.
Psychiatry research 1983;8(2):105-9.
1983: J Y Hsieh; R K Yang; Kenneth L Davis
Improved sample preparation before liquid-chromatographic determination of probenecid in cerebrospinal fluid.
Clinical chemistry 1983;29(1):213-4.
1983: B M Davis; A A Mathé; Richard C Mohs; M I Levy; Kenneth L Davis
Effects of propantheline bromide on basal growth hormone, cortisol and prolactin levels.
Psychoneuroendocrinology 1983;8(1):103-7.
1983: Kenneth L Davis; Richard C Mohs; B M Davis; T B Horvath; Blaine Greenwald; W G Rosen; M I Levy; C A Johns
Oral physostigmine in Alzheimer's disease.
Psychopharmacology bulletin 1983;19(3):451-3.
1983: Richard C Mohs; W G Rosen; Kenneth L Davis
The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.
Psychopharmacology bulletin 1983;19(3):448-50.
1983: C A Johns; Blaine Greenwald; Richard C Mohs; Kenneth L Davis
The cholinergic treatment strategy in aging and senile dementia.
Psychopharmacology bulletin 1983;19(2):185-97.
1983: Blaine Greenwald; Kenneth L Davis
Experimental pharmacology of Alzheimer disease.
Advances in neurology 1983;38():87-102.
1982: Kenneth L Davis; Richard C Mohs
Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
The American journal of psychiatry 1982;139(11):1421-4.
1982: Kenneth L Davis; J Y Hsieh; M I Levy; T B Horvath; B M Davis; Richard C Mohs
Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type.
Psychopharmacology bulletin 1982;18(4):193-5.
1982: K S Kendler; J Y Hsieh; Kenneth L Davis
Studies of plasma homovanillic acid as an index of brain dopamine function.
Psychopharmacology bulletin 1982;18(4):152-5.
1982: G S Rosenberg; Kenneth L Davis
The use of cholinergic precursors in neuropsychiatric diseases.
The American journal of clinical nutrition 1982;36(4):709-20.
1982: S M Stahl; Kenneth L Davis; P A Berger
The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
Journal of clinical psychopharmacology 1982;2(5):321-8.
1982: Richard C Mohs; B M Davis; G S Rosenberg; Kenneth L Davis; D T Krieger
Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma.
Life sciences 1982;30(21):1827-33.
1982: K S Kendler; H S Bracha; Kenneth L Davis
Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
European journal of pharmacology 1982;79(3-4):217-23.
1982: M I Levy; Y DeNigris; Kenneth L Davis
Rapid antidepressant activity of melanocyte-inhibiting factor: a clinical trial.
Biological psychiatry 1982;17(2):259-63.
1982: Stephen Irwin Deutsch; Richard C Mohs; Kenneth L Davis
A rationale for studying the transmissibility of Alzheimer's disease.
Neurobiology of aging 1982;3(2):145-7.
1982: M I Levy; Richard C Mohs; W G Rosen; Kenneth L Davis
Research subject recruitment for gerontological studies of pharmacological agents.
Neurobiology of aging 1982;3(1):77-9.
1982: G S Rosenberg; Kenneth L Davis
Precursors of acetylcholine: considerations underlying their use in Tourette syndrome.
Advances in neurology 1982;35():407-12.
1982: Richard C Mohs; Kenneth L Davis
A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.
Neurobiology of aging 1982;3(2):105-10.
1982: B M Davis; G M Brown; Myron Miller; H G Friesen; A J Kastin; Kenneth L Davis
Effects of cholinergic stimulation on pituitary hormone release.
Psychoneuroendocrinology 1982;7(4):347-54.
1981: A B Rothpearl; Richard C Mohs; Kenneth L Davis
Statistical power in biological psychiatry.
Psychiatry research 1981;5(3):257-66.
1981: Kenneth L Davis; L E Hollister; A A Mathé; B M Davis; A B Rothpearl; K F Faull; J Y Hsieh; J D Barchas; P A Berger
Neuroendocrine and neurochemical measurements in depression.
The American journal of psychiatry 1981;138(12):1555-62.
1981: Richard C Mohs; Kenneth L Davis; M I Levy
Partial reversal of anticholinergic amnesia by choline chloride.
Life sciences 1981;29(13):1317-23.
1981: Kenneth L Davis; A Samuel; A A Mathé; Richard C Mohs
Intracerebral des-tyrosine-gamma-endorphin inhibits methylphenidate induced locomotor activity.
Life sciences 1981;28(21):2421-4.
1981: Kenneth L Davis; G S Rosenberg
Induction of behavioral supersensitivity to apomorphine by DFP treatment.
Life sciences 1981;28(17):1953-9.
1981: B M Davis; A Pfefferbaum; S Krutzik; Kenneth L Davis
Lithium's effect of parathyroid hormone.
The American journal of psychiatry 1981;138(4):489-92.
1981: K S Kendler; Kenneth L Davis
The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses.
Schizophrenia bulletin 1981;7(4):689-709.
1981: Kenneth L Davis; K F Faull; L E Hollister; J D Barchas; P A Berger
Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.
Psychopharmacology 1981;72(2):155-60.
1980: Kenneth L Davis; Richard C Mohs; B M Davis; T B Horvath; J R Tinklenberg; G S Rosenberg; M I Levy
Human memory and the effects of physostigmine and choline chloride [proceedings].
Psychopharmacology bulletin 1980;16(4):27-8.
1980: L E Hollister; Kenneth L Davis; P A Berger
Subtypes of depression based on excretion of MHPG and response to nortriptyline.
Archives of general psychiatry 1980;37(10):1107-10.
1980: P A Berger; Stanley J Watson Jr; Huda Akil; G R Elliott; R T Rubin; A Pfefferbaum; Kenneth L Davis; J D Barchas; C H Li
beta-Endorphin and schizophrenia.
Archives of general psychiatry 1980;37(6):635-40.
1980: Richard C Mohs; Kenneth L Davis
Choline chloride effects on memory: correlation with the effects of physostigmine.
Psychiatry research 1980;2(2):149-56.
1980: B M Davis; Kenneth L Davis
CKholinergic mechanisms and anterior pituitary hormone secretion.
Biological psychiatry 1980;15(2):303-10.
1980: L E Hollister; A Pfefferbaum; Kenneth L Davis
Monitoring nortriptyline plasma concentrations.
The American journal of psychiatry 1980;137(4):485-6.
1980: P A Berger; K F Faull; J Kilkowski; P J Anderson; H Kraemer; Kenneth L Davis; J D Barchas
CSF monoamine metabolites in depression and schizophrenia.
The American journal of psychiatry 1980;137(2):174-80.
1980: Kenneth L Davis; Richard C Mohs; J R Tinklenberg; L E Hollister; A Pfefferbaum; B S Kopell
Cholinomimetics and memory. The effect of choline chloride.
Archives of neurology 1980;37(1):49-52.
1980: Richard C Mohs; Kenneth L Davis; J R Tinklenberg; L E Hollister
Choline chloride effects on memory in the elderly.
Neurobiology of aging 1980;1(1):21-5.
1980: L E Hollister; Kenneth L Davis; P A Berger
Apomorphine in schizophrenia.
Communications in psychopharmacology 1980;4(4):277-81.
1979: Kenneth L Davis; L E Hollister; P A Berger
Choline chloride in schizophrenia.
The American journal of psychiatry 1979;136(12):1581-4.
1979: Kenneth L Davis; Richard C Mohs; J R Tinklenberg
Enhancement of memory by physostigmine.
The New England journal of medicine 1979;301(17):946.
1979: Richard C Mohs; Kenneth L Davis; J R Tinklenberg; L E Hollister; J A Yesavage; B S Kopell
Choline chloride treatment of memory deficits in the elderly.
The American journal of psychiatry 1979;136(10):1275-7.
1979: Kenneth L Davis
Cholinomimetic treatment of neuropsychiatric disorders: a review of recent developments.
The Mount Sinai journal of medicine, New York 1979;46(5):455-9.
1979: Kenneth L Davis; G S Rosenberg
Is there a limbic system equivalent of tardive dyskinesia?
Biological psychiatry 1979;14(4):699-703.
1979: Kenneth L Davis; L E Hollister; J Livesey; P A Berger
Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders.
Psychopharmacology 1979;63(2):155-9.
1979: Kenneth L Davis; L E Hollister; A L Vento; B A Beilstein; G R Rosekind
Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.
Psychopharmacology 1979;63(2):143-6.
1979: A Pfefferbaum; Kenneth L Davis; C L Coulter; Richard C Mohs; J R Tinklenberg; B S Kopell
EEG effects of physostigmine and choline chloride in humans.
Psychopharmacology 1979;62(3):225-33.
1979: R S Williams; R M Crowell; C M Fisher; Kenneth L Davis; M H Lavyne; A H Ropper; A M Bremer
Clinical and radiologic remission in reticulum cell sarcoma of the brain.
Archives of neurology 1979;36(4):206-10.
1978: L E Hollister; Kenneth L Davis; J E Overall; T Anderson
Excretion of MHPG in normal subjects: implications for biological classification of affective disorders.
Archives of general psychiatry 1978;35(12):1410-5.
1978: Kenneth L Davis; Henry I Yamamura
Cholinergic underactivity in human memory disorders.
Life sciences 1978;23(17-18):1729-33.
1978: Kenneth L Davis; L E Hollister; W C Fritz
Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol.
Life sciences 1978;23(15):1543-8.
1978: Kenneth L Davis; L E Hollister; P A Berger; A L Vento
Studies on choline chloride in neuropsychiatric disease: human and animal data.
Psychopharmacology bulletin 1978;14(4):56-8.
1978: Kenneth L Davis; Richard C Mohs; J R Tinklenberg; A Pfefferbaum; L E Hollister; B S Kopell
Physostigmine: improvement of long-term memory processes in normal humans.
Science (New York, N.Y.) 1978;201(4352):272-4.
1978: L E Hollister; D J Jenden; J R Amaral; J D Barchas; Kenneth L Davis; P A Berger
Plasma concentrations of choline in man following choline chloride.
Life sciences 1978;23(1):17-22.
1978: Kenneth L Davis; L E Hollister; A L Vento; S Simonton
Choline chloride in methylphenidate- and apomorphine-induced stereotypy.
Life sciences 1978;22(24):2171-7.
1978: Kenneth L Davis; P A Berger; L E Hollister; J D Barchas
Cholinergic involvement in mental disorders.
Life sciences 1978;22(21):1865-71.
1978: Kenneth L Davis; L E Hollister; A L Vento; S Simonton
Choline chloride in animal models of tardive dyskinesia.
Life sciences 1978;22(19):1699-707.
1978: Kenneth L Davis; P A Berger
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Biological psychiatry 1978;13(1):23-49.
1978: Kenneth L Davis; L E Hollister; J Tepper
Cholinergic inhibition of methylphenidate-induced stereotypy: oxotremorine.
Psychopharmacology 1978;56(1):1-4.
1978: Kenneth L Davis; P A Berger; L E Hollister; E Defraites
Physostigmine in mania.
Archives of general psychiatry 1978;35(1):119-22.
1977: B M Wermuth; Kenneth L Davis; L E Hollister; A J Stunkard
Phenytoin treatment of the binge-eating syndrome.
The American journal of psychiatry 1977;134(11):1249-53.
1977: Kenneth L Davis; L E Hollister; F K Goodwin; E K Gordon
Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine.
Life sciences 1977;21(7):933-6.
1977: Kenneth L Davis; P A Berger; L E Hollister
Deanol in tardive dyskinesia.
The American journal of psychiatry 1977;134(7):807.
1977: Kenneth L Davis; P A Berger; L E Hollister; S C Simonton
Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report.
Psychopharmacology bulletin 1977;13(3):37-8.
1977: E G De Fraites; Kenneth L Davis; P A Berger
Coexisting tardive dyskinesia and parkinsonism: a case report.
Biological psychiatry 1977;12(2):267-72.
1976: Kenneth L Davis; L E Hollister; J Overall; A Johnson; K Train
Physostigmine: effects on cognition and affect in normal subjects.
Psychopharmacology 1976;51(1):23-7.
1976: Kenneth L Davis; L E Hollister; J D Barchas; P A Berger
Choline in tardive dyskinesia and Huntington's disease.
Life sciences 1976;19(10):1507-15.
1976: L E Hollister; Kenneth L Davis; P A Berger
Pituitary response to thyrotropin-releasing hormone in depression.
Archives of general psychiatry 1976;33(11):1393-96.
1976: Kenneth L Davis; L E Hollister; P A Berger
Letter: Bacloffen in schizophrenia.
Lancet 1976;1(7971):1245.
1976: Kenneth L Davis; P A Berger; L E Hollister
Tardive dyskinesia and depressive illness.
Psychopharmacology communications 1976;2(2):125-30.
1975: Kenneth L Davis; L E Hossister; P A Berger
Thyrotropin-releasing hormone in schizophrenia.
The American journal of psychiatry 1975;132(9):951-3.
1975: Kenneth L Davis; P A Berger; L E Hollister
Letter: Choline for tardive dyskinesia.
The New England journal of medicine 1975;293(3):152.
1975: L E Hollister; Kenneth L Davis; P A Berger
Butaclamol hydrochloride in newly admitted schizophrenics.
Psychopharmacology communications 1975;1(5):493-500.
1975: Kenneth L Davis; L E Hollister; P A Berger; J D Barchas
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
Psychopharmacology communications 1975;1(5):533-43.
1974: Kenneth L Davis; B Qualls; L Hollister; A J Stunkard
Letter: EEGs of "binge" eaters.
The American journal of psychiatry 1974;131(12):1409.
1974: B Shopsin; S Wilk; G Sathananthan; S Gershon; Kenneth L Davis
Catecholamines and affective disorders revised: a critical assessment.
The Journal of nervous and mental disease 1974;158(5):369-83.
1973: B Shopsin; S Wilk; S Gershon; Kenneth L Davis; M Suhl
Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.
Archives of general psychiatry 1973;28(2):230-3.